Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
Clinical trial NCT04260152 · COMPLETED
Trial details
- NCT number
- NCT04260152
- Sponsor
- Geistlich Pharma AG
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2020-01-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.